New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 5, 2014
09:24 EDTMNKD, ARNAMannKind shares may fall after Afrezza approval, Feuerstein says
MannKind (MNKD) shares are likely to go higher into the July 15 FDA decision on Afrezza, but are likely to sell off following the drug's approval, The Street's Adam Feuerstein argues. Feuerstein lays out similarities between MannKind and Arena Pharmaceuticals (ARNA). Reference Link
News For MNKD;ARNA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 29, 2014
19:32 EDTMNKDMannKind confirms receipt of $150M licensing upfront payment
Subscribe for More Information
September 26, 2014
07:32 EDTARNABioCentury to hold a conference
21st Annual NewsMakers in the Biotech Industry Conference to be held in New York on September 26.
September 24, 2014
17:01 EDTMNKDMannKind announces closing of global licensing agreement with Sanofi
Subscribe for More Information
September 17, 2014
07:43 EDTARNABofA/Merrill to hold a conference
Subscribe for More Information
05:51 EDTMNKDStocks with implied volatility movement; OREX MNKD
Stocks with implied volatility movement; Orexigen (OREX) 91, MannKind (MNKD) 60 according to iVolatility.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use